Suraksha Diagnostic (SURAKSHA) | Stock Overview & Key Data
Suraksha Diagnostic Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹449.00 on December 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Suraksha Diagnostic
SURAKSHA
|
14.71B Small-cap | -2.70% | -12.26% | 6.83% | -5.81% | -1.79% | -18.17% | -35.76% | -35.76% | -35.76% | -35.76% | -35.76% |
|
Dr. Lal PathLabs
LALPATHLAB
|
238.92B Large-cap | 4.53% | 0.82% | 20.51% | 13.04% | 7.03% | 8.45% | 58.06% | 0.84% | 257.00% | 257.46% | 257.46% |
|
Sai Life Sciences
SAILIFE
|
217.06B Large-cap | 1.11% | 10.73% | 23.70% | 32.85% | 34.17% | 58.19% | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% |
|
Vimta Labs
VIMTALABS
|
20.49B Small-cap | 3.62% | 21.20% | 32.32% | -10.43% | -9.23% | 7.98% | 167.33% | 353.31% | 1,474.04% | 3,502.92% | 522.03% |
|
Krsnaa Diagnostics
KRSNAA
|
19.83B Small-cap | 0.61% | -7.81% | -10.16% | -28.11% | -27.24% | -21.15% | -7.70% | -42.36% | -42.36% | -42.36% | -42.36% |
|
Qualitek Labs
QLL
|
3.59B Small-cap | 0.22% | 15.46% | 32.25% | 2.48% | 4.30% | 43.88% | 141.56% | 141.56% | 141.56% | 141.56% | 141.56% |
Ownership & Short Interest
Calculate Your Suraksha Diagnostic Investment Returns
Long-Term Investment Performance Analysis
Suraksha Diagnostic stock price in Dec 2024 was ₹417.25, A ₹1,000.00 lump sum investment in Suraksha Diagnostic made 1 years ago would be worth approximately ₹642.90 today, representing a negative return of -35.71%. This translates to an annualized return (CAGR) of -25.03%.
1 Year 6 Months Investment Scenario (Dec 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SURAKSHA's 52-week high and low?
- In the last 52 weeks, Suraksha Diagnostic reached a high of ₹352.50 (on June 25, 2025) and a low of ₹224.10 (on March 30, 2026).
- What is the market cap and P/E ratio for SURAKSHA?
- Curious about Suraksha Diagnostic's size and valuation? Its market capitalization stands at 14.71B. When it comes to valuation, the P/E ratio (trailing twelve months) is 45.27, and the forward P/E (looking ahead) is 36.69.
- Does SURAKSHA pay dividends? If so, what's the yield?
- As for dividends, Suraksha Diagnostic isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Suraksha Diagnostic's main competitors or similar companies to consider before investing?
When looking at Suraksha Diagnostic, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB238.92B Healthcare Diagnostics & Research 8.45% 58.06% Sai Life Sciences
SAILIFE217.06B Healthcare Diagnostics & Research 58.19% 73.11% Vimta Labs
VIMTALABS20.49B Healthcare Diagnostics & Research 7.98% 167.33% Krsnaa Diagnostics
KRSNAA19.83B Healthcare Diagnostics & Research -21.15% -7.70% Qualitek Labs
QLL3.59B Healthcare Diagnostics & Research 43.88% 141.56% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Suraksha Diagnostic Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Suraksha Diagnostic's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.14%, the Debt to Equity ratio from the most recent quarter is 51.30, and its Gross Profit Margin stands at 88.84%.
- What is the recent revenue and earnings growth for SURAKSHA?
- Looking at Suraksha Diagnostic's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 29.20%, and quarterly earnings saw a YoY growth of 22.30%.
- How much of SURAKSHA stock is held by insiders and institutions?
- Wondering who owns Suraksha Diagnostic stock? Company insiders (like executives and directors) hold about 61.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 22.15%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.